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Cancer-related fatigue in post-treatment
cancer survivors: application of the
common sense model of illness
representations
Teresa Corbett* , AnnMarie Groarke, Jane C. Walsh and Brian E. McGuire
Abstract
Background: Cancer-related fatigue (CrF) is a common and disruptive symptom that may be experienced during
and after cancer. Research into the subjective experience of fatigue in this group is required. The common sense
model of self-regulation of health and illness (SRM) addresses personal beliefs or mental representations—whether
medically sound or unsubstantiated— that a person holds about a health issue. The current study assesses if the
SRM could be used as a theoretical framework for organizing the experiences of people with CrF, with a view to
identifying methods to address fatigue in cancer survivors.
Method: Four focus groups were held with a total of 18 cancer survivors who reported they experienced
‘significant fatigue or reduced energy.’ A thematic analysis was conducted within the framework of the SRM.
Results: Findings were aligned with the SRM, with participants discussing fatigue with reference to representation,
coping, and appraisal of symptoms. In particular, the wider social context of CrF was frequently addressed.
Perceived inadequacies in support available to those with lingering fatigue after the completion of cancer
treatment were highlighted by the participants.
Conclusion: This study explored the subjective experience of fatigue after cancer using the SRM. CrF should be
approached as a complex psychosocial issue and considered from the patient perspective to facilitate better
understanding and management of symptoms. The SRM is an applicable framework for identifying modifiable
factors that could lead to improved coping with CrF in post-treatment cancer survivors.
Background
Up to 75 % of post-treatment cancer survivors expe-
rience negative health-related consequences [1]. The
exploration of late effects of treatment, ongoing symp-
toms, survivorship care and self-management is now
considered a priority [2]. Cancer survivors have specific
emotional and physical needs [3], and research into
these areas requires input from survivors [4].
Cancer-related fatigue (CrF) is the most common and
disruptive symptom experienced by cancer survivors. It
is a distressing, persistent, subjective feeling of physical,
emotional and/or cognitive tiredness associated with
cancer or cancer treatment [5]. CrF is more severe,
enduring, and debilitating than “normal” fatigue caused
by lack of sleep or overexertion and it is not relieved by
sleep or rest [6]. Fatigue during treatment is a risk factor
for developing chronic CrF following treatment [7]. Up
to 30 % of cancer survivors experience persistent fatigue
for years after cancer diagnosis [8]. It is an often un-treated
symptom that contributes to diminished functioning, re-
duced quality of life, and socioeconomic consequences
[9, 10]. Recently is an increased focus on the needs
associated with treatment-induced symptoms of post-
treatment cancer survivors [11]. These persistent negative
effects delay the patients’ return to normal life [12].
Fatigue is often described as a medically-contested
illness [13]. Individuals with fatigue report that a
‘medicalised’ self-identity is unavailable to them, in
contrast to those impaired due to medically- and
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socially- legitimated illnesses [14]. The ‘invisible’ na-
ture of fatigue may lead others to discredit patients’
illness experiences [15] and those with CrF have de-
scribed a lack of understanding from family, friends
and health professionals [16]. Consequently, they are
often left to make sense of and manage CrF by them-
selves. A greater understanding of patient beliefs
about their fatigue would be useful given evidence
that certain types of thoughts (e.g., catastrophising)
are associated with CrF [17].
The underlying aetiology of CrF is not well understood
[18] but it is thought to be a complex process associated
with physical, mental, and emotional aspects. Minton et
al [19] note that the processes that cause and maintain
fatigue overtime remain unclear. An inflammatory re-
sponse to both the cancer itself and the range of treat-
ment modalities has been linked to fatigue. [20]. Given
that those who are post-treatment would generally be
expected to improve overtime (when disease and treat-
ment side effects had abated), it is hypothesised that
other factors may lead to prolonged fatigue during sur-
vivorship. A cognitive-behavioural model of CrF posits
that biological insults such as cancer or its treatment
may precipitate the initial experience of fatigue during
cancer, but behavioural and cognitive factors may aggra-
vate and prolong fatigue in survivorship [17]. Thus the
aims of this study are to explore the experience of
fatigue in those after treatment rather than discussing
the cancer experience or trajectory. In some instances,
experiences particular to the individuals’ cancer experi-
ence were mentioned. However as outlined in the inter-
view schedule, unless the comments referred directly to
fatigue after cancer, these were not the focus of the study
(see Appendix 2).
Guidelines for the support of individuals with CrF
following treatment recommend the use of cognitive-
behavioural therapy (CBT) [21, 22]. CBT aims to in-
fluence or change cognitions, emotions, behaviours,
or a combination of these [23]. Interventions which
target these processes may improve symptom manage-
ment in cancer-related fatigue [24]. These interven-
tions target knowledge, emotional adjustment, quality
of life, coping skills, physical health and functional
adjustment [25].
CBT interventions focus on similar cognitive, emo-
tional and coping/behavioural factors as those outlined
by Leventhal’s [26, 27] common sense model of self-
regulation (or self-regulation model: SRM). This theoret-
ical framework may, therefore, provide a useful approach
to understanding post-treatment CrF with potential for
informing the design of interventions based on cogni-
tive–behavioural principles.
The SRM suggests that illness information - whether
medically sound or unsubstantiated - is evaluated and
integrated by the individual to provide a ‘lay’ under-
standing of the symptom or illness. Illness representa-
tions may be guided by current and prior awareness of
symptoms, or by social messages from perceived signifi-
cant others or authoritative sources [28]. Processing of
information occurs in three stages: representation, cop-
ing, and appraisal [14].
The individual’s representation of illness is proposed
to have 5 components [27]: identity (the name or label
applied to the symptoms), timeline (the perceived time
trajectory for the symptoms), consequences (expected
future effects and outcomes due to symptoms), causes
(beliefs about aetiology of the symptoms) and control
(the extent to which the patient believes that they can
gain personal control over the symptoms). Coping is
guided by illness representations [29] and involves
implementing responses for managing the symptoms or
the emotional responses that follow. Viewing illness and
symptoms as controllable is linked to active coping,
whereas perceptions that symptoms are uncontrollable
and chronic have been found to be associated with
avoidance and denial coping [30]. An individual also
appraises the effectiveness of their coping efforts [31]
and this evaluation may result in a change in coping
strategy and/or a change in perception of the illness and
its symptoms [32].
The model has proved useful across many health con-
ditions [29] with considerable evidence linking elements
of the SRM to psychological functioning in a wide range
of illnesses [30, 32, 33]. Few studies, report on how
survivors describe CrF, highlighting the need for re-
search from the patient perspective [15] and only one
study to date [34] has examined the fit of the patient
experience of CrF with the concepts from the SRM. In
that study, the majority of patient statements were clas-
sified as mental representations of fatigue, with fewer
references to coping and appraisal. The authors con-
cluded that the SRM was a valid organizing framework
for CrF in patients undergoing treatment [34]. However,
the experience of fatigue is likely to be different when
the patient transitions into long-term survivorship [35].
The utility of the SRM at this later stage awaits investiga-
tion. Reviews of the literature have not reported on a trial
that has used the SRM as a theoretical framework under-
pinning research into CrF in cancer survivors [36, 37].
Pertl et al. [14] carried out a thematic discourse analysis
on the ‘additional comments’ left by 73 fatigued cancer
patients and survivors as part of a questionnaire study on
CrF. However, it may be the case that the questionnaire
primed comments on related topics. Further, less than half
the participants provided comments [14]. In order to build
on these findings, this study used focus groups in order to
allow participants to discuss the experience in more depth
and with others who experience similar symptoms.
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Accordingly, this qualitative study examines if the
SRM is a useful framework to conceptualise CrF in
long-term cancer survivors. In turn, this model may
prove to be a useful integrated theoretical model for de-
veloping, evaluating and explaining the underlying
mechanisms involved in CBT interventions for CrF. The
use of such a model could enhance our understanding of
the complex processes involved in the development and
maintenance of CrF in some individuals.
Methods
Procedure
In line with Medical Research Council (MRC) guidelines
[38], this study sought to identify if SRM theory could
potentially be relevant and useful in the design of a psy-
chological intervention for fatigue in post-treatment can-
cer survivors.
A contextualist approach was adopted to acknowledge
the meanings applied to, and reality of, the experience of
CrF, and to understand how the broader social context
impacts on those meanings [39].
Focus groups were used as they enable discussion
about the subjective experience of persistent fatigue, and
they facilitate conversation about a topic that is not
often addressed [40]. The study protocol was approved
by the Institutional University Research Ethics Commit-
tee of the National University of Ireland Galway, Ireland.
Details of the research procedure can be seen in Table 1.
An interview script was designed in line with the ques-
tions asked by Barsevik et al [34] (See Appendix 2).
Thematic analysis was employed to identify, analyse
and report themes within the data [42]. Further details
of this process can be seen in Table 2.
The study was reported using the consolidated criteria
for reporting qualitative research (COREQ) checklist for
focus groups to ensure rigor in reporting in how the
study was conducted.
Other features of the research that ensured validity
[43] included:
 Clear statement of the aims of the research
 Justification of the methodology and research design
used
 Ethical approval received for study
 Use of an interview schedule that was established a
priori
 Rigor in data analysis achieved by following pre-
defined steps of how to conduct thematic analysis
 Use of a coding manual for consistent analyses
 Use of interrater- coding in the data analyses
Participants
Irish cancer survivors who self-reported ‘significant
fatigue or reduced energy’ were eligible to take part. All
participants were Caucasian. Four focus groups were
held with 18 participants (Mean age 59.83, SD = 10.34).
(See Table 3). Smaller groups were selected as- given the
somewhat sensitive nature of the topic- the researchers
felt that it may be difficult to get meaningful interaction
among the participants in a larger group. The smaller num-
ber of participants, therefore, allowed for greater in-depth
discussion in this exploratory research. Analysis of these dis-
cussions is based on themes that were reflective of patterns
in the overall data rather than a reporting of the proportion
of participants or groups expressing a theme. Participants
gave consent to take part in a discussion about their fatigue
and were informed that the sessions would be recorded.
Results
Participants reported that they valued the opportunity to
discuss their experience with post-treatment CrF and
enjoyed comparing their experiences with similar others.
Individuals spoke freely, with little need for prompting
from the facilitator. Details of the analyses and coding
process can be seen in the coding manual (Appendix 1.)
Analyses identified major themes that could be under-
stood within the processes of the SRM: representation of
symptoms; coping; appraisal of coping. The impact of the
wider social context in the individual’s representation of
their CrF was an overarching theme. These themes are de-
scribed in further detail below and are illustrated in Fig. 1.
Social context
The social context of fatigue was discussed. Participants
were concerned that their symptoms were a deviation
from the norm. The general public was perceived as not
having a good understanding of fatigue. One participant
(age 53, 36 months post-treatment) asserted that, “It’s
more socially acceptable in society to say ‘I’m a cancer
patient’, than ‘I suffer from fatigue’.”
Social identity
The participants described the experience of CrF within
the context of their own complex lives [44]. Participants
did not want to worry their family or friends, and felt
under pressure not to appear to be complaining. One
woman (age 44, 72 months post-treatment) said “you’re
trying to explain to them that you’re tired and you’re flat
and you just have no interest. Sometimes it’s hard to
articulate.” Individuals reported frustration at platitudes
offered by others. Failure of others to understand that
CrF was different from ‘normal’ fatigue, aging, or being
busy was a common problem. One man (age 58,
26 months post-treatment) said, “My friends and col-
leagues said “Look, we’re all getting old. It’s not you and
your cancer at all. It’s just your age.” As with previous
studies, the findings indicated that understanding and
support from others could be beneficial, but many often
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Table 1 Consolidated criteria for reporting qualitative research (COREQ) checklist [76] for focus groups
Item Description
Domain 1: Research team and reflexivity
Personal Characteristics
1. Interviewer/facilitator Two authors (TC and BMG) conducted the focus groups
2. Credentials TC: BA, MSc
BMG: BA, MClinPsych, DipCrim, DipHealthSc, PhD, AFPsSI, Reg Psychol (PsSI), AFBPsS, CPsychol
3. Occupation TC: PhD candidate
BMG: Research Leader and Clinical Psychologist
4. Gender TC: female
BMG: male
5. Experience and training TC: trained in qualitative research methods and design; experience in conducting focus groups
BMG: trained in qualitative research methods and design; experience in facilitating clinical groups
Relationship with participants
6. Relationship established Participants contacted TC via email or telephone to discuss arrangements for the focus groups.
Otherwise participants had no relationship with researchers
7. Participant knowledge of the interviewer Participants were informed that the researcher was conducting a PhD in the area of cancer related
fatigue and that her goal was to understand the symptom better by discussing it with people
who lived with it.
8. Interviewer characteristics Qualitative researcher and supervisor were both closely engaged in the research process
and were therefore unable to completely avoid personal bias. This research sought to inform
the content of an intervention.
Domain 2: study design
Theoretical framework
9. Methodological orientation and Theory Thematic analysis was used in this study. A contextualist approach was adopted to acknowledge
the meanings applied to, and reality of, the experience of CrF, and to understand how the broader
social context impacts on those meanings [39].
Participant selection
10. Sampling Cancer survivors who self-reported ‘significant fatigue or reduced energy’ were eligible to take part.
Self-selected Irish cancer survivors from the general public participated in this research.
11. Method of approach From February to June 2014, cancer support groups and associations in the region were contacted.
A press release was distributed to local media groups advertising the study.
12. Sample size There were 18 participants in the study. There were four individuals in each of the first three focus
groups and the final group had six attendees.
13. Non-participation All participants who agreed on a date and time to attend took part in the focus groups.
Setting
14. Setting of data collection Data was collected in a meeting room in the School of Psychology at the University where
the researcher is based.
15. Presence of non-participants No one else was present besides the participants and researchers.
16. Description of sample Demographic data can be seen in Table 3.
Data collection
17. Interview guide Questions based on a study by Barsevik et al [34] were utilised. These open-ended questions were
posed to each of the groups: (a) what is your experience of fatigue? (b) What does the experience
of fatigue mean to you? and (c) what do you do about your fatigue? These were the primary
questions asked, with other topics being addressed as the conversation developed. If an opportune
moment arose, other questions from Barsevik et al [34] were also included: (a) are there different
types of fatigue? (b) How do other symptoms affect fatigue? and (c) what do you and/or your
doctors and nurses recommend to manage fatigue?
18. Repeat interviews No repeat interviews were carried out.
19. Audio/visual recording Audio recording was used to collect the data.
20. Field notes Field notes were made during and after the focus group.
21. Duration Each of the focus groups was approximately 90 min in duration.
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felt misunderstood and isolated when the reality of the
“new normal” was not fully appreciated [44, 45]. Com-
parisons were likely if participants knew of others who
had not experienced fatigue after cancer treatment. One
woman (age 44, 72 months post-treatment) said that it
“makes you question it even more because you’re saying
“why am I not like them?” Meeting similar others helped
participants to accept their own fatigue. One man (age
67, 7 months post-treatment) described how “all of a
sudden you realize that so many people have the same
problem”.
Participants discussed relationships and responsibil-
ities. One woman (age 44, 72 months post-treatment)
described pressure from her family to return to ‘normal’
saying “It helps them cope as well. Because they see you
as not being sick anymore and so they are indirectly
pushing you to get back to your normal routine.” One
man (age 52, 7 months post-treatment) lamented the
impact that CrF had had on his relationship with his son
saying, “I wouldn't be able to go playing ball with him.
He’s gotten to where he doesn’t ask me. It’s a loss.”
Interaction with healthcare service
Perceptions of fatigue were impacted by the reactions of
healthcare professionals to CrF. Participants felt that
they were not adequately forewarned that fatigue would
persist after treatment. Many said that fatigue “was never
mentioned.” One person (age 53, 36 months post-
treatment) noted that although fatigue was mentioned,
“nobody said 3 years down the line you’re still going to
be nodding off.”
Table 1 Consolidated criteria for reporting qualitative research (COREQ) checklist [76] for focus groups (Continued)
22. Data saturation The researchers decided that data saturation had been achieved after the fourth focus group.
The transcripts were reviewed as soon as possible after each interview. Saturation was achieved
as no further additional new information began to emerge. It was agreed that the addition of
new codes was unlikely after the fourth focus group [77].
23. Transcripts returned Transcripts were not returned to participants for comment and/or correction.
Domain 3: analysis and findings
Data analysis
24. Number of data coders Two data coders (TC and AMG) coded the data
25. Description of the coding tree Coding Tree can be seen in Fig. 1.
26. Derivation of themes Themes were identified in advance based on theory. The identified themes are reflective of patterns
in the data and aim to provide a unified picture. Two researchers agreed on a clearly specified
thematic coding manual which guided the interpretation of the data.
27. Software Data was managed by hand
28. Participant checking Participants did not provide feedback on the findings.
Reporting
29. Quotations presented Participant quotations were presented to illustrate the themes/findings. Each quotation identified
using the participants’ age, gender, and cancer diagnosis.
30. Data and findings consistent There is consistency between the data presented and the findings. The unit of analyses was the
theme rather than the prevalence or frequency of statements. Some statements of quantification
are included (e.g., statements such as often, sometimes), but do not always aim to provide estimates
of prevalence.
31. Clarity of major themes Codes identified in the open coding stage were discussed by two study authors until consensus
was reached. A coding manual was developed (See Table 4 in Appendix 1) to clarify and define
each of the themes. In stage two, the codes were checked in relation to pre-defined themes
based on SRM. All major themes clearly presented in the findings.
32. Clarity of minor themes There is a description of minor themes in the findings.
Table 2 Process of data analysis
1. Coding was initially data-driven using an inductive approach to ensure
that the data was analysed comprehensively, without trying to fit it into
a pre-existing model or analytic preconceptions (Braun and Clarke, 2006
[39]). Two researchers (TC and AMG) processed initial features of the data
that were of interest (codes). Each transcript was analysed separately and
emerging codes were compared across groups. Discrepancies were
discussed with co-authors (JW and BMG) until consensus was reached.
2. At the next stage of data analysis there was a shift towards the
broader level of themes. Themes were items that represented some
level of patterned meaning within the data (Braun & Clarke, 2006 [39]).
Codes were organised using a theoretical thematic analysis, driven by
SRM theory [41]. The analysis of the codes was
theory-driven in order to address the specific research question, “Do
participants’ subjective accounts fit with the components of the SRM?”
3. As themes were refined, the data set was reviewed to ensure that selected
themes ‘worked’ and to identify any data that may have been previously
overlooked. A thematic map of the data was produced (See Fig. 1).
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Participants thought that doctors were dismissive when
they mentioned fatigue. One woman (age 60, 18 months
post-treatment) felt that her G.P. “practically laughed”
when fatigue was mentioned. She believed that doctors
were “more into the treatment and you mention tiredness,
they ignore you. It was swept under the carpet.” Others
agreed that healthcare providers were slow to engage in a
conversation about fatigue. One man (age 52, 7 months
post-treatment) said “I feel like I’m telling her [the doctor]
I’m tired all the time. She thinks I’m cuckoo.” Another
man (age 77, 36 months post-treatment) described how
his doctors carried out various tests when he complained
about fatigue, “but not one of them has even acknowledged
that it might be because I had cancer”.
Positive experiences with healthcare professionals were
also mentioned. One man (age 67, 7 months post-
treatment) said he was “lucky that I’ve a very good GP
and he does listen. We do talk about fatigue.” Many cited
family members who worked in a healthcare profession
as a support in terms of information provision and
reassurance, especially in light of perceived gaps in care
elsewhere.
Participants criticised a non-holistic approach to care,
reporting that once physical causes of their fatigue were
ruled out, their symptoms were often ignored. One
participant (age 60, 18 months post-treatment) felt that
healthcare professionals “were very quick about curing
things but they never worry about side-effects.” Others
considered fatigue “a psychological aspect of the illness
and the treatment that’s been left open ended” (age 68,
42 months post-treatment). One man (age 67, 7 months
post-treatment) said “You’re left lonely. You’re left not
having that support that you thought that the doctor
might be able to give you.”
Participants believed that ‘quality of life’ was an
emerging concept in cancer care and influenced the
recognition of side-effects such as fatigue. One man
(age 77, 36 months post-treatment) suggested that
“maybe the reason the medical profession are in
denial is that they don’t know how to cure it. They
certainly don’t acknowledge it at all. It’s not within
their competence to do anything about it so they just
conveniently don’t recognise it.”
Cognitive and emotional representations of health threat
Identity
Participants voiced frustration that a label or definition
of CrF was not provided to them. Acknowledgement of
fatigue was viewed as a tool for acceptance that could
reduce worry about the symptom and would justify the
“right to be tired” (age 60, 18 months post-treatment).
People emphasised the reality of fatigue, expressing the
belief that fatigue was not something wholly psycho-
logical. One man (age 52, 7 months post-treatment)
Table 3 Demographic information for each of the participants
Gender Age- Range Cancer Type Treatment Type Time since
treatment (months)Chemotherapy Radiotherapy Surgery Other
Male 66–80 Prostate x Hormonal therapy 36
Male 66–80 Prostate x Decopeptyl injections 7
Male 66–80 Prostate Brachytherapy 60
Female 56–65 Breast x 18
Female 66–80 Breast x x 42
Female 56–65 Breast x x 36
Female 66–80 Breast Stage III ductal x x x 72
Female 40–55 Breast x x 18
Female 56–65 Breast x x x 9
Female 40–55 Breast x x 24
Female 56–65 Triple Negative Breast x x x 36
Male 66–80 Bowel and liver x x 18
Female 56–65 Stomach x x x 72
Male 66–80 Stomach x 24
Male 40–55 Testicular x x 48
Male 56–65 Rectum x x x 26
Female 40–55 Non-Hodgkin Lymphoma x x 72
Male 40–55 Lymphoma x x 7
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said “it’s not imaginary. You really feel it. This exhaus-
tion is true. It’s too strong.” Another woman (age 53,
36 months post-treatment) echoed this sentiment
saying “there is not something wrong with our heads. It
is actually real.”
The lack of an available discourse for CrF influenced
how people made sense of their symptoms, influencing
the perceived cause, timeline, and controllability of CrF,
in turn affecting their ability to cope with fatigue. One
person (age 43, 24 months post-treatment) said, “I was
beginning to think that I was going silently crazy or
something.” Inadequate support was also raised as a
potential causal factor in fatigue. One woman (age 60,
36 months post-treatment) believed that fatigue “hits
later down the line because you’re not in any cocoon.
There is nobody there to look after you for the fatigue.”
Participants described having numerous medical tests
that aimed to identify a physiological cause for the
fatigue. These tests were often invasive and inconvenient.
Importantly, they were also seen to reduce the valid-
ity of fatigue as an issue in and of itself, which led
to feelings of confusion, uncertainty, and fear. Un-
certainty about fatigue was also discussed in terms
of the chronicity of fatigue. Participants wondered
“is this the way it’s going to be? Or will this ease?”
(Age 43, 24 months post-treatment). Some felt that
they should be “better by now” (age 58, 26 months
post-treatment). Doubt surrounding the prolonged
experience of CrF led to emotional consequences.
Many were uncertain if their fatigue was in line with
their predicted time for recovery, with one saying “I
keep thinking this can’t be right. I cannot be this
tired after three and a half years” (age 60, 36 months
post-treatment).
Cause
Fatigue was attributed to the culmination of stress dur-
ing cancer. Others felt that they had taken on too much
Fig. 1 “A Self-Regulation Model of Cancer-Related Fatigue”
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too soon after treatment, describing ‘pressure on yourself
to get back to your normal routine” (age 60, 18 months
post-treatment). Potential biological causes were also
mentioned, including inflammation, endorphins, or cyto-
kines. The role of cancer treatment in the development
of symptoms was raised, with one noting “The treatment
made me tired. Treatment is worse than illness in some
cases” (age 67, 7 months post-treatment). A lack of con-
centration or ‘chemo-brain’ was also cited as a potential
cause of fatigue. One participant (age 44, 72 months
post-treatment) said “You can’t focus and that- men-
tally- is kind of just adding to the tiredness.”
Emotional responses, including fears of cancer recur-
rence, were also linked to the presence of fatigue. One
woman worried that “the cancer must be back. I think
sometimes is there a bit of a bad cell left floating around
in me that’s causing it?” (Age 60, 36 months post-
treatment).
Habits and mood were mentioned as possible causes
of fatigue. One man (age 71, 18 months post-treatment)
asked “would tiredness be related to worry?” Participants
distinguished between fatigue and depression. Rather
than attributing low mood to depressive symptoms,
participants recognised low mood as being related by
feeling “so tired, you feel down because you’re not
going to be able to do anything today” (age 52,
7 months post-treatment)
Consequence
The impact of fatigue on quality of life and functional
capacity was discussed, with one participant asking
“Without energy what can you have?” (Age 55,
18 months post-treatment). Participants described
learning to reconceptualise energy as a limited re-
source, as there was a ‘cost’ of activity and over-
exertion. People avoided certain situations “because it
just won’t be worth it” (age 44, 72 months post-
treatment). One participant (age 53, 36 months post-
treatment) said that “Cancer was not the worst ordeal
of my life. The diagnosis, the treatment, the surgery
wasn’t debilitating- didn’t stop me from doing anything.
But the fatigue does…” The persistence of fatigue
delayed return to a sense of ‘normality.’
Fatigue challenged the self-concept of many partici-
pants, with one noting “it impacts on me not being
able to be who I am” (age 60, 36 months post-
treatment). One woman (age 43, 24 months post-
treatment) observed that “you’re not able to do the
things you want to do or you’re not where you want
to be”. Social lives were interrupted due to fatigue,
resulting in “a feeling of isolation” (age 68, 42 months
post-treatment). Some believed that fatigue was
responsible for a lack of concentration and led to
procrastination.
Fatigue had forced some individuals into early retire-
ment, even when they “had no intention of retiring just
yet” (age 67, 7 months post-treatment). One participant
(age 44, 72 months post-treatment) said that she “just
could not face going back to work. I just really didn’t
have the energy.” One woman (age 60, 36 months post-
treatment) described how retirement due to ill-health
was “part of a kind of a rejection”.
Participants emphasised the “difference between being
tired and fatigue” (age 53, 36 months post-treatment).
One (age 60, 18 months post-treatment) spoke about
how “sleeping doesn’t seem to cure it,” saying that “every
day for me was a groundhog day”. Some reported heavy
sleep at night. For others, getting to sleep posed a prob-
lem. One woman (age 68, 42 months post-treatment)
stated that she had trouble “staying asleep and then
nodding off during the day.
In terms of emotional representations, participants
worried about fatigue, with one woman saying she found
herself “fretting to high heaven about it” (age 60,
18 months post-treatment). Another described how
“thinking about it brings on anxiety” (age 76, 24 months
post-treatment). Distress as a consequence of CrF was
addressed. One participant (age 57, 72 months post-
treatment) pointed out that “no matter how you try to be
positive about it, it does get you down. It affects you
mentally.”
Participants felt guilty and ashamed about functional
limitations, low energy levels, and pressure from others.
One woman (age 68, 42 months post-treatment) regret-
ted “lost days”. A mother in the group (age 44,
72 months post-treatment) said CrF affected her rela-
tionship with her children, feeling “guilty because I
didn’t do more things with them”. Another participant
(age 60, 36 months post-treatment) felt she was “a fail-
ure”, saying “it’s not that I’m depressed. I’m frustrated.
The only time I was ever angry about having cancer
is the fact that it’s left me with fatigue.” Another
agreed that it was “quite frustrating, debilitating in ways”
(age 43, 24 months post-treatment). A belief that partici-
pants ‘should’ be happy to have beaten cancer was also
debated.
Timeline
Fatigue was described as having changed over time, and
as being persistent. People described a “dead tiredness,
all the time” (age 44, 72 months post-treatment) and
how fatigue “won’t go. It lingers” (age 60, 36 months
post-treatment). Another explained, “When you’re tired
all the time it seems to drag on” (Age 43, 24 months
post-treatment).
The onset of fatigue during the day was addressed by
participants. One (age 60, 18 months post-treatment)
described fatigue “creeping over me… gradually getting
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more and more tired. Until eventually you are flat-
tened.” Another experienced “a weakness all over”
upon waking and felt “very sluggish in the morning”
(age 43, 24 months post-treatment). Participants de-
scribed a predictive pattern of fatigue, with one (age
67, 60 months post-treatment) saying “you could
nearly time yourself by it”.
For certain individuals, fatigue symptoms had dimin-
ished over time. Some viewed fatigue as an acute symp-
tom that would not go on forever. One (age 58,
26 months post-treatment) said “I’m hoping it’ll go away.
I thought I’d be ok this year but maybe next year.”
Cure/control
Many participants believed that they had a lack of
control over their tiredness. One (age 66, 72 months
post-treatment) described her fatigue as “totally uncon-
trollable”. Another (age 52, 7 months post-treatment)
mentioned that “Sometimes you would just have to go to
sleep.” Conversely, others felt that they had gained
control over their CrF, saying “I think that it’s in your
own hands and you have to plan and you have to
work your way out of this lethargy” (age 67, 7 months
post-treatment).
Coping: strategies used to alleviate fatigue
Active coping strategies
Positive reinterpretation was discussed as a means of
staying optimistic with persistent fatigue. One woman
(age 66, 72 months post-treatment) said it was necessary
to “be kinder to yourself. Be more forgiving.” Some con-
sidered fatigue a small price to pay for surviving cancer.
One (age 68, 42 months post-treatment) said that she
was “lucky to be here even though I feel wiped out”.
Participants preferred not to give into their fatigue,
with one participant (age 58, 26 months post-treatment)
saying “whatever I do, I won’t sleep during the day
because if I sleep during the day I won’t sleep at night.”
Some used exercise to alleviate fatigue. One woman (age
53, 36 months post-treatment) said “If you do get really
tired, don’t sit. Go for a walk. Go out and do something.
It can be the antidote.” Another (age 57, 72 months
post-treatment) said “the more energy you use the more
you get to replace it.”
Participants sought advice, assistance, or information
from doctors and support centres. For some, support
received during cancer had extended into longer-term
survivorship due to fatigue. One participant (age 59,
9 months post-treatment) noted “I had my sister when I
was sick to keep the house ticking over and she’s still
there.” Individuals sought out others for moral support,
sympathy, or understanding. One participant felt “it’s im-
portant to be out among people. You can’t be isolated”
(age 59, 9 months post-treatment). This included
support from other fatigued cancer survivors, with one
man (age 67, 60 months post-treatment) concluding that
“we can learn from one another.”
Planning helped participants to prepare coping strat-
egies. One woman (age 44, 72 months post-treatment)
said “I just have to pace myself. You plan events. You
have rest days before and afterwards. Make adjustments.
You know you’re going to be flat.”
Acceptance and emotion-focused coping
One described a process of learning “to pace yourself
better” and to “recognize your own limits” (age 44,
72 months post-treatment). This was not always easy;
one participant (age 60, 18 months post-treatment) said
“I don’t do things because I know I’m going to be tired. I
know the consequence of it.”
Acceptance of fatigue was difficult. One woman (age
60, 18 months post-treatment) voiced her frustration,
saying “who wants to listen to their body? You just want
to go out and enjoy yourself.” Another said that he “just
can’t accept it” (age 52, 7 months post-treatment),
whereas others felt it was important to acknowledge the
reality of their situation. Another group member (age
60, 36 months post-treatment) reflected on how she felt
she could cope better as a result of how she understood
her symptoms, stating, “I can manage my life if I know
I’m going to be tired.”
Distraction, resting and avoiding activity as coping
strategies
Individuals often disengaged from activity to cope
with fatigue. Napping was mentioned as a coping
strategy, with one woman (age 60, 18 months post-
treatment) saying that she sleeps “on the couch
every single evening”. Research on CrF suggests that
it may be better to avoid long or late afternoon
naps as the combination of less daytime activity
and more daytime sleep is associated with increased
levels of CrF [36, 46, 47].
Mental disengagement was employed by participants
to distract themselves from fatigue and the stress of
dealing with it. One (age 43, 24 months post-
treatment) said that she tries to “forget about it and
keep going”, but in turn, described how she then feels
more tired later as a consequence. The groups dis-
cussed the importance of recognising physical limita-
tions rather than disengaging from them. Taking
breaks and rest were discussed as useful. One woman
(age 68, 42 months post-treatment) said “Listen to
your body. It’s saying slow down.” Another (age 71,
18 months post-treatment) suggested “if your body’s
tired, just go away for 5 min and when you come
back you’ll get through the day no problem.” However,
this was contested with one participant (age 60,
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18 months post-treatment) saying, “but when you
raise your family… and you’re getting into your 60s
and you want to go out and enjoy life… who wants to
listen to their body? You just want to go out and
enjoy yourself.” One man (age 52, 7 months post-
treatment), stated, “Basically I don’t do things because
I know I’m going to be tired. I just don’t do anything
then because I know the consequence of it- that the
recovery period is too long- and I say “sure it’s not
worth it in the end”… so I don’t bother.”
Participants felt it was sometimes best to avoid
competing, distracting, or tiring activities. Learning to
say “no” was recognised as an important skill for
participants.
Appraisal of coping strategies
While participants were not asked explicitly to appraise
the effectiveness of their coping, it was considered that
certain questions could capture elements of this (“what
do you do about your fatigue?” or “how do other
symptoms affect fatigue?”)
In addition, in some instances the question “What
have you found “works” for your fatigue” was included
but these were not based on the Barsevik questions
and arose naturally as the interviews progressed (See
Appendix 2).
Within that context, the impact of the coping styles or
strategies adopted was discussed. Participants discussed
acceptance as a particularly important overall coping
strategy. One woman (age 68, 42 months post-
treatment) said “I find I accept it now. It’s there. Deal
with it. You either have a solution or you learn to live
with it.” Another (age 44, 72 months post-treatment)
explained that “you can reason with it better once you
know that it’s got a name.”
Some felt that their current coping strategies were
ineffective. One woman (age 60, 18 months post-
treatment) said “I don’t do anything. I sit down and get
very depressed. I’m not a very accepting person. I want to
be like the way I was before it happened.” Another (age
57, 72 months post-treatment) felt that her attitude
prevented her from engaging in effective coping “I go
walking if I think I’m only going for a mile. Maybe I can’t
manage it. But I couldn’t do it if I thought I was going
for three miles. I don’t know is it my legs or my mind-set,
you know? That’s the problem. Maybe my legs would take
me the other two miles, but I can’t.”
One man (age 52, 7 months post-treatment) described
how “some days you’d push yourself to do something and
you knew you were tired but you’d achieve it. There is a
great sense of achievement when you do something.”
Another (age 58, 26 months post-treatment) said “I’m
coping with it ok but I’m just finding time is long and I’d
like to be back doing a full day’s work again but
unfortunately just I’m not able for that yet.’ Participants
identified challenges, with one woman (age 44, 72 months
post-treatment) describing how initially she was "so tired
and so flat”, and that “it was only when the fog lifted” that
her family began to return to their “own little routine and
our own little life”. In appraising her coping, she felt that
“it got easier once I recognized that you can’t do everything
that you used to do.”
These findings are depicted in Fig. 1.
Discussion
These findings add to published quantitative and qualita-
tive research to provide further understanding of the
subjective experience of CrF in post-treatment cancer
survivors. The SRM was developed to represent ‘lay’ un-
derstanding of illness experiences across all populations,
yet to date very little research has applied the model to
the experience of cancer survivors [32]. Findings in the
current study, demonstrate that subjective experiences
of post-treatment cancer survivors with CrF fit with the
constructs of cognitive and emotional representations,
coping strategies and appraisal as outlined in the SRM.
This is in line with similar research conducted by Pertl
et al (14) who conducted a thematic discourse analysis
on the ‘additional comments’ of a questionnaire study
on CrF in cancer survivors. Fatigue was understood as a
part of the cancer experience that extended into longer-
term survivorship. Without access to an available narra-
tive to describe their experience, individuals engaged in
a process of making sense of the fatigue themselves [14].
Participants emphasised the role of others, highlight-
ing the influence of wider social discourse on their
experience of fatigue. Dealing with social pressure to
return to ‘normal’ after cancer was difficult for partici-
pants. Feelings of isolation associated with others’ lack
of understanding regarding CrF might contribute to the
symptom burden [48]. The social response to symptoms
influenced participant representations of and coping
with CrF, with some participants reporting hesitations in
discussing their symptoms and feeling distressed or
guilty as a consequence of CrF. Research has previously
indicated that the social context is extremely pertinent to
how representations are formed [49]. As with previous
studies, the findings indicated that the social context of
the “new normal” was crucial in how participants under-
stood their symptoms. Reactions and support from others
influenced these perceptions, and the coping response that
followed [44, 45]. This serves to demonstrate the align-
ment of survivors’ views with the CrF. The individual’s
coping with, and appraisal of, CrF can modify illness
representations (i.e., in a feedback loop- See Fig. 1.) [30].
These qualitative results provide further insight into the
specific ways that both the individuals’ perspective and the
influence of social factors should be acknowledged in
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those with CrF. Individual perceptions and social context,
as well as disease and treatment characteristics are im-
portant in planning survivorship care [50]. The SRM
could be a useful framework for healthcare professionals
to apply in assessments of survivor’s physical and psycho-
social characteristics in order to effectively tailor care [51].
Many statements focused on the “identity” of CrF.
A label was seen as a vehicle to accepting fatigue. In
line with previous research, recognition of symptoms
was considered crucial in learning to cope with fa-
tigue and articulating the experience to others, in-
cluding health professionals [52]. Barker et al [53]
emphasised the significance of having a name for
medically unexplained symptoms. The current study
also showed that fatigue had far-reaching social and
emotional consequences for participants. Many emo-
tional consequences were associated with uncertainty
that arose due to lack of recognition of CrF by
others. Behavioural consequences such as the incon-
venience of medical testing were also often linked to
this uncertainty. Discussions relating to the timeline
of CrF were similarly dominated by a sense of ambi-
guity. Likewise, individuals did not report a sense of
control over their symptoms. Participants were not
sure what to expect because CrF had already persisted
longer than anticipated after the end of treatment.
Others have also noted the link between cancer-
related uncertainty and psychophysiological disrup-
tions, highlighting a need to target this ambiguity in
interventions for CrF (30). Factors such as com-
prehensibility, manageability, and meaningfulness can
influence symptom perception. A sense of coherence
may serve as a protective psychological factor in the
adaptation process [54, 55].
The representations impacted on acceptance of fatigue
and affected participants’ coping, as shown in previous
research [56]. Perceived lack of support from family
members and healthcare providers, as well as difficulties
in trying to understand CrF also influenced participants’
ability to cope. Some participants described engaging in
“active” coping strategies, such as exercise in managing
CRF. Others reported taking naps or avoiding activity.
Thus, participants may choose more maladaptive strat-
egies for fatigue (e.g., daily/frequent napping) rather than
recommended strategies (e.g., exercise [57]) depending
on their representation of CrF. Beliefs about fatigue
management influence coping strategies following can-
cer treatment [58].
Participants did not spontaneously appraise or reflect
on the particular coping strategies they used to manage
CrF. Evaluations focused more on general appraisals of
attempts to regain a sense of ‘normality’ after treat-
ment. Whitaker, Scott and Wardle [59] note that fac-
tors such as high external demands (e.g., family and
work commitments) can impact interpretation of symp-
toms. Co-morbidities, stereotypes, and perceptions of
aging can also bias appraisal of coping and expectations
[37]. Acknowledgement of symptom seriousness from
others may facilitate individual acceptance of fatigue
and encourage appraisal of current coping strategies
[59]. Current results add to those of a previous study
which noted that appraisals of representations have
been linked to seeking care in response to ambiguous
[60] and prolonged symptoms [61]. Understanding how
individuals appraise coping could help guide the devel-
opment of tailored, proactive interventions to improve
well-being [58].
Taken overall, this study suggests that the dynamic,
self-regulatory structure of the SRM could serve as the
basis for developing interventions for improving fatigue
management [56]. This study extends on previous re-
search that applied the SRM to patients’ experiences
during cancer treatment [34, 62], providing insight into
the unique representations of CrF in cancer survivors
[63]. Persistent fatigue does not conform to generally
accepted conceptualisations of survivorship, with treat-
ment as an end-point of care [64].
The findings highlight a need for continued support to
enhance quality of life after cancer treatment [35, 63].
Cancer itself and/or treatment initially trigger fatigue,
but other factors may be responsible for persistence of
CrF [17]. Exercise or psychosocial interventions are cur-
rently the treatment modalities of choice [65]. Existing
interventions for CrF have focused on perpetuating
factors such as beliefs and behaviours associated with
fatigue, often using strategies based on cognitive behav-
iour therapy (CBT) [66]. CBT is a practical application
of many of the theoretical constructs addressed in the
SRM [67]. Very few randomized trials have explicitly ap-
plied the SRM to influence self-regulative symptom
management [56]. None have explored how the SRM
could be applied in interventions for CrF after cancer.
SRM-based strategies could target how individuals think,
feel and cope with their fatigue [56]. This study, there-
fore, concentrated solely on the fit of the discussions to
the SRM rather than considering alternative models.
Dempster et al [32] found that illness perceptions and
coping play an important role in studies that link the
SRM to wellbeing outcomes. It is still unclear how
illness representations relate to coping, and how this
might be applied in interventions (17). The current
study suggests that interventions for CrF should be
two-fold, targeting and measuring both the represen-
tation of symptoms and coping strategies [62]. A ‘top-
down’ SRM approach to CrF would aim to create an
overarching cognitive and emotional representation of
fatigue as a manageable symptom, with coping and
appraisal as targets for behaviour change [56]. In line
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with calls for improved methods of identifying and
reporting the components of interventions, such an
approach would need to assess the theoretical con-
structs of the SRM as proposed mechanisms of any
change in fatigue symptoms [68].
Limitations
Some limitations of this study should be acknowledged.
As the participants self-selected, this may have re-
sulted in a biased sample not representing the wider
population. Those frustrated with fatigue problems
might have been more likely to self-nominate to partici-
pate in this research. Conversely, significantly fatigued
people may have not felt well enough to participate. As
this was an exploratory study of an under-researched
symptom in Irish cancer survivors, it was decided that
specific purposive sampling methods were not appropri-
ate. This sampling method reflected the methods that
would be used in any future intervention arising from
the findings, and would give a sense of perceived need/
interest in the topic from the community. However, the
authors recognise that the current study may be sus-
ceptible to selection biases, in particular regarding the
disproportionate number of breast cancer survivors who
participated. For example, Wenger and Oliffe [69]
suggest that men may be less comfortable discussing
distressing situations or symptoms, and may feel more
cautious about who they consider a safe source of
support.
The collection of data via focus groups means that
participants may conform to the perspectives of others
in the group and findings may not reflect the views of
individual participants [70]. Care was taken to ensure
that each participant was given ample opportunity to
express their perspective, however, some were naturally
inclined to speak more than others. Researchers did
make efforts to keep dominant respondents from taking
over discussion.
The groups engaged in a free-flowing conversation
with relatively little input from the researchers. However,
issues raised by participants were likely to depend on
their circumstances at the time of participation [71].
Although a variety of cancer types and treatments
were represented, a more heterogeneous sample would
broaden the content of the representations, coping strat-
egies, and appraisals. Furthermore, information relating to
education level was not gathered. Some evidence pub-
lished prior to this research had suggested that factors
such as ethnicity, educational attainment, and employ-
ment status were not associated with fatigue [72, 73].
However, recent evidence (published since the focus
groups were conducted) suggests that lower education
and pre-existing comorbidities may be associated with
fatigue [74, 75].
Attempts were made to avoid bias in how the data was
collected and interpreted. The moderators of the groups
were experienced in qualitative research and followed an
interview schedule. Questions were designed to be
neutral and answerable. General questions were asked
before specific questions.
While there were advantages to conducting qualita-
tive rather than quantitative survey-based methods to
learn more about CrF, some limitations must be con-
sidered. The analysis of these discussions is based on
themes that were reflective of patterns in the overall
data rather than a reporting of the proportion of par-
ticipants or groups expressing a theme. Using qualita-
tive methods did not provide information regarding
the proportion or frequency of particular responses
(See Table 1. Point 30).
The first author of this paper analysed the data and
was also a moderator in the focus groups. This may have
resulted in bias when reporting the findings. Experi-
ences, beliefs, goals of the researcher and personality
could bias analysis and reporting. However, efforts were
made to minimise this bias by specifying the questions a
priori in an interview schedule and following a coding
manual. In addition, inter-rater reliability was used in
the coding process.
Conclusion
Overall, results indicated that post-treatment CrF
can be described using concepts from the SRM. The
findings contribute to the literature on the reconcep-
tualization of cancer as a chronic illness by identify-
ing perceived inadequacies in support available to
those left with lingering side-effects after the com-
pletion of cancer treatment. The study demonstrated
the complexity of the individuals’ meaning-making
processes when the legitimacy of the health concern
is contested. The current research identified specific
elements of the SRM that were very pertinent for
those with CrF. Participants felt inadequately pre-
pared for persistent fatigue after cancer and were left
confused, isolated and frustrated as a result. CrF
should be approached as a complex psychosocial
issue and considered from the patient perspective to
facilitate better understanding and management of
symptoms.
Prevailing models of healthcare promote patient-
centered care for control of chronic symptoms and
highlight the need for evidence based practice [38, 56].
Importantly, this study highlights how the SRM
could be applied to CrF in post-treatment cancer
survivors by providing a theoretical framework for
understanding individuals’ representations, and cop-
ing strategies, and thus identifying targets for in-
tervention [68].
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Appendix 1
Table 4 Code book
The SRM hypothesises that individuals create mental representations of
their illness based on the concrete and abstract sources of information
available to them in order to make sense of and manage the problem.
It is the interpretation of this information that forms the first step in the
process of seeking help, engaging in a coping strategy, or adopting an
illness management regimen [78].
Social Context Abstract and concrete sources of information
The perception and interpretation of the different
sources of information influence other aspects of
the participants’ perception of fatigue, including
representations, coping with and appraisal of
fatigue via symmetrical conceptual (abstract and
prepositional) and schematic (concrete and
perceptual) processes.
Label Social Messages
Definition The first source is information from the external social
environment from perceived significant others. This
refers to the general pool of ‘lay’ information already
assimilated by the individual from previous social
communication and cultural knowledge of the illness.
Description •Deviation from norm
• Source: Media/Similar others/family/friends
• Type: vague/inaccurate/extensive/detailed
Includes: how social response to the reports of their
fatigue symptom is assimilated by the individual and
in turn, impacts their acceptance and representation
of the symptoms:
• Reactions of and support offered by healthcare
professionals
• Reactions of and support offered by family and friends
Code2
Label Social Identity
Definition This source of information relates to participants’ social
role and identity. The expectations of others are
included, as well issues that arise due to difficulties
in articulating the experience of symptoms.
Description • Expectations of others
• Social comparisons (comparison to similar others)
• Individuals role as parent/friend/employee








Definition Dimension represents the beliefs regarding the factors







Table 4 Code book (Continued)
Code 6
Label Consequence
Definition imagined and real refers to beliefs regarding the
impact of the illness on overall quality of life or








Definition i.e., the time for the development of the disease,
its duration, and time for recovery;
Refers to the individual’s beliefs about the course
of the illness (e.g., “My illness is chronic”) and time







Definition Degree to which the disease can be prevented,
cured, and kept from progressing.
refers to the sensation of empowerment regarding
performance of coping behaviours or the efficacy
of treatment




Definition Cognitive and behavioural actions we take (or do not
take) to enhance health and to prevent, treat (i.e.,
cure or control), and rehabilitate from illness.
Description •Distraction, Resting and Avoiding Activity
• Problem-focused coping
• Seeking social support.
• Problem-focused coping–specific.
As in Martin S. Hagger & Sheina Orbell (2003) A
Meta-Analytic Review of the Common-Sense
Model of Illness Representations, Psychology & Health,




Definition Symptom and functional changes
Evaluation of coping style/strategies adopted
Description •What factors influenced coping?
•Was my coping strategy effective?
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Appendix 2
Focus Groups 2014 - Cancer-related fatigue
Interview schedule followed by interviewers during
the focus groups. The aims of the interviews are
outlined. The schedule also includes the semi-
structured interview script that guided the focus
group interviews.
The purpose of these focus group interviews is to
discuss personal experiences of CRF from adult survi-
vors of cancer. In particular, the study will aim to gather
descriptions of the patients’ understanding of CRF and
examine the fit of their descriptions to a theoretical
model.
Does want to know:
1. How adults represent and understand their fatigue
symptoms.
2. How adults cope with CRF
3. How adults appraise the impact of CRF.
Does not want to know:
1. how cancer in general has impacted their life
2. how they think others deal with or cope with
fatigue
Goals of the research
General
➢ Develop a general understanding of target groups’
perceptions of CRF
➢ Identify the language and key concepts that the
group uses to discuss CRF
➢ To frame the theoretical basis of the intervention.
(i.e., To establish if Illness Perception theory could be
applied in an Irish discussion of CRF)
Specific
➢ Key ideas that relate to the topic are identified
➢ The importance or significance of these key ideas
can be described
➢ How strongly the participants feel about these key
ideas can be identified
➢ Language and vocabulary are identified that relate
to CRF and can be used in communication with
participants.
➢ Solicit ideas in relation to the potential for an
online intervention for CRF
➢ Questions and information from participants are
available to assist with the further development of the
research questions and purposes.
➢ Information from participants will verify hypothesis
or help in refining hypotheses.
Moderators’ guide: interview schedule
a) Introduction
a. Welcome
i. “Welcome and thank you for coming to this
focus group. Each of you has been invited to
participate because your view is important to
us. We know that you are very busy and we
greatly appreciate your contribution to this
project. This interview is not a test, nor should
it in any way be viewed as a series of
questions with right or wrong answers.
Remember, we are very interested in what you
think and feel. We want to know your opinions
on these issues, and we are certainly not
interested in your agreeing with the opinions
and feelings of others. There may be times,
however, when you do, and it is appropriate
for you to let us know that as well.”
ii. Here I have a participant information sheet
for you to read. Once you’re happy that you’re
clear on what is expected of you, you can sign
our consent form. I can answer any questions
you have.
b. Purpose
i. “The purpose of this focus group interview is to
discuss your personal experiences of cancer-
related fatigue, as survivors of cancer.”
c. Guidelines
i. “There are a few guidelines I would like to ask
you to follow during the focus group interview.
Frist, you do not need to speak in any
particular order. When you have something to
say, please do so.
ii. Second, please do not speak while someone
else is talking. Sometimes, the exchanges get
emotional, and it is tempting to ‘jump in’
when someone is talking, but we ask you to
refrain from doing so.
iii. Third, remember that there are many people
in the group and it is important that we
obtain the point of view of each one of you.
Fourth, you do not need to agree with what
everyone or anyone in the group says, but you
do need to state your point of view without
making any negative comments or ‘put downs’.
iv. Finally, because we have limited time together,
I may need to stop you and to redirect our
discussion. Does anyone have any questions?
Ok, let’s begin
b) Warm-up
a. Set the tone
i. During the reception you had an opportunity
to meet each other and to ask each other
Corbett et al. BMC Cancer  (2016) 16:919 Page 14 of 17
questions. To get the ball rolling, let’s start off
with a brief introduction about yourself. Maybe
tell us what type of cancer you had and how
long it’s been since your treatment finished.
b. Set participants at ease
c) Clarification of terms
a. Establish the knowledge base of key terms
through questions
b. Provide definitions of key terms
i. Just so that we’re all clear, I’m going to give
you the standard textbook definition of
cancer-related fatigue before we begin. It is de-
fined as “a distressing persistent sense of tired-
ness or exhaustion related to cancer that is not
proportional to recent activity and interferes
with usual functioning”.
ii. What is your experience of fatigue?
d) Establish Easy and non-threatening questions
a. The initial questions should be general and less
threatening
i. What does the experience of fatigue mean to you
ii. What do you do about your fatigue
e) Establish More difficult questions
a. The more difficult or personal questions should
be determined
i. Are there different types of fatigue
ii. How do other symptoms affect fatigue
f ) Wrap-up
a. Identify and organize the major themes from the
participant’s responses
i. Ok so from today it seems that we’ve covered
quite a lot and heard some interesting points.
b. Ensure that any conversational points not
completed are mentioned
i. Unfortunately we didn’t have time to
discuss….. further, but if you want to find out
more you can contact some of the services on
your Participant Information sheet
g) Member-Check
a. Determine how each member perceives selected
issues
h) Closing statements
a. Request anonymity of information
b. Answer any remaining questions
i. Has anyone any remaining questions about
anything we’ve discussed today?
c. Express thanks
i. Great! Thank you very much for coming today.
Your help is greatly appreciated
Other questions
 What is fatigue
 Signs of fatigue
 What causes fatigue in cancer survivors…
treatment? Or other causes such as pain, emotional
distress, sleep problems, medications, nutrition,
lack of exercise etc.?
 How to manage fatigue?
 How to cope with fatigue?
 How to find out more about fatigue? - Newspaper?
Doctor? Online? Nurse? etc.?
 When did the fatigue first start?
 When did you notice that this fatigue is different
from usual?
 Does anything make it better? Worse?
 Do you have any other problems or concerns?
 How has the fatigue affected the things you do
every day?
 Do you use the internet to find out about
symptoms?
 What do you and/or your doctors and nurses
recommend to manage fatigue
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